Cargando…
Evaluation of treatment response and symptom progression in 400 patients with visual snow syndrome
AIMS: To gather information on useful medications to treat visual snow syndrome (VSS) as well as to validate an instrument to assess its clinical severity and the course of the disorder over time. METHODS: Four hundred patients with VSS were included in this web-based prospective questionnaire study...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411880/ https://www.ncbi.nlm.nih.gov/pubmed/34656983 http://dx.doi.org/10.1136/bjophthalmol-2020-318653 |
_version_ | 1784775364427382784 |
---|---|
author | Puledda, Francesca Vandenbussche, Nicolas Moreno-Ajona, David Eren, Ozan Schankin, Christoph Goadsby, Peter J |
author_facet | Puledda, Francesca Vandenbussche, Nicolas Moreno-Ajona, David Eren, Ozan Schankin, Christoph Goadsby, Peter J |
author_sort | Puledda, Francesca |
collection | PubMed |
description | AIMS: To gather information on useful medications to treat visual snow syndrome (VSS) as well as to validate an instrument to assess its clinical severity and the course of the disorder over time. METHODS: Four hundred patients with VSS were included in this web-based prospective questionnaire study. All subjects completed a treatment questionnaire and a clinical diary. The first allowed evaluation of the effects of previous medications on visual snow, while the second measured VSS symptoms daily over the course of 30 days. RESULTS: Patients commonly reported previous use of medications such as antidepressants, antiepileptics, antibiotics and benzodiazepines. However, none of these drug classes was beneficial for the majority of patients. Recreational drugs and alcohol worsened visual snow symptoms in several reports. Vitamins and benzodiazepines had high therapeutic ratios, although in most cases they did not change the course of VSS. The monthly diary confirmed that the static in VSS is a consistent symptom over time. It also showed that indoor and fluorescent lights have a worse effect on symptoms when compared with natural outdoor lighting. CONCLUSIONS: The study confirms clinical experience that medications are generally ineffective in VSS, with the exception of vitamins and perhaps benzodiazepines, which could be beneficial in some patients. The 30-day diary represents a useful tool to measure symptom progression over time, which could be used in future trials on VSS. |
format | Online Article Text |
id | pubmed-9411880 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-94118802022-09-12 Evaluation of treatment response and symptom progression in 400 patients with visual snow syndrome Puledda, Francesca Vandenbussche, Nicolas Moreno-Ajona, David Eren, Ozan Schankin, Christoph Goadsby, Peter J Br J Ophthalmol Clinical Science AIMS: To gather information on useful medications to treat visual snow syndrome (VSS) as well as to validate an instrument to assess its clinical severity and the course of the disorder over time. METHODS: Four hundred patients with VSS were included in this web-based prospective questionnaire study. All subjects completed a treatment questionnaire and a clinical diary. The first allowed evaluation of the effects of previous medications on visual snow, while the second measured VSS symptoms daily over the course of 30 days. RESULTS: Patients commonly reported previous use of medications such as antidepressants, antiepileptics, antibiotics and benzodiazepines. However, none of these drug classes was beneficial for the majority of patients. Recreational drugs and alcohol worsened visual snow symptoms in several reports. Vitamins and benzodiazepines had high therapeutic ratios, although in most cases they did not change the course of VSS. The monthly diary confirmed that the static in VSS is a consistent symptom over time. It also showed that indoor and fluorescent lights have a worse effect on symptoms when compared with natural outdoor lighting. CONCLUSIONS: The study confirms clinical experience that medications are generally ineffective in VSS, with the exception of vitamins and perhaps benzodiazepines, which could be beneficial in some patients. The 30-day diary represents a useful tool to measure symptom progression over time, which could be used in future trials on VSS. BMJ Publishing Group 2022-09 2021-10-16 /pmc/articles/PMC9411880/ /pubmed/34656983 http://dx.doi.org/10.1136/bjophthalmol-2020-318653 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Clinical Science Puledda, Francesca Vandenbussche, Nicolas Moreno-Ajona, David Eren, Ozan Schankin, Christoph Goadsby, Peter J Evaluation of treatment response and symptom progression in 400 patients with visual snow syndrome |
title | Evaluation of treatment response and symptom progression in 400 patients with visual snow syndrome |
title_full | Evaluation of treatment response and symptom progression in 400 patients with visual snow syndrome |
title_fullStr | Evaluation of treatment response and symptom progression in 400 patients with visual snow syndrome |
title_full_unstemmed | Evaluation of treatment response and symptom progression in 400 patients with visual snow syndrome |
title_short | Evaluation of treatment response and symptom progression in 400 patients with visual snow syndrome |
title_sort | evaluation of treatment response and symptom progression in 400 patients with visual snow syndrome |
topic | Clinical Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411880/ https://www.ncbi.nlm.nih.gov/pubmed/34656983 http://dx.doi.org/10.1136/bjophthalmol-2020-318653 |
work_keys_str_mv | AT puleddafrancesca evaluationoftreatmentresponseandsymptomprogressionin400patientswithvisualsnowsyndrome AT vandenbusschenicolas evaluationoftreatmentresponseandsymptomprogressionin400patientswithvisualsnowsyndrome AT morenoajonadavid evaluationoftreatmentresponseandsymptomprogressionin400patientswithvisualsnowsyndrome AT erenozan evaluationoftreatmentresponseandsymptomprogressionin400patientswithvisualsnowsyndrome AT schankinchristoph evaluationoftreatmentresponseandsymptomprogressionin400patientswithvisualsnowsyndrome AT goadsbypeterj evaluationoftreatmentresponseandsymptomprogressionin400patientswithvisualsnowsyndrome |